Nasdaq approved the listing of a Canary Capital exchange-traded fund that stakes the Injective (INJ) token on November 4, 2026, and the fund began trading the next day under the ticker INJC, according to filings with the U.S. Securities and Exchange Commission (SEC).
The same filings show the fund must keep at least 90% of its INJ holdings staked, with custody handled by BitGo. Canary Capital projects it will keep up to 70% of the staking payout before paying its 1.10% yearly sponsor fee and other costs.
The listing marks the first US-regulated fund tied to INJ, letting investors gain exposure without buying or storing the token themselves.
INJ rose nearly 9% in 24 hours and traded around $7.91 on the morning of November 5, according to KuCoin.


